Experienced in Disseminated Tuberculosis

Sivaporn Gatechompol

Bangkok, TH 
Clinical Trials:Currently Recruiting for 1 Trial
Experienced in Disseminated Tuberculosis
Bangkok, TH 
OverviewLocationsClinical Research

Overview

Sivaporn Gatechompol practices in Bangkok, Thailand. Gatechompol is rated as an Experienced expert by MediFind in the treatment of Disseminated Tuberculosis. Their top areas of expertise are HIV/AIDS, Human Papillomavirus Infection, Cirrhosis, and Disseminated Tuberculosis.

Their clinical research consists of co-authoring 54 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Disseminated Tuberculosis.

Locations

Bangkok, Thailand
Other Locations
104 Ratchadamri Rd, Pathumwan, Ratchadamri, 10330, Thailand

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Efficacy, Safety and Pharmacokinetics of Dolutegravir 50 Mg Once Daily with Food Versus Dolutegravir 50 Mg Twice Daily in HIV/TB Co-infected Patients Receiving Rifampin-based Antituberculosis Therapy
Efficacy, Safety and Pharmacokinetics of Dolutegravir 50 Mg Once Daily with Food Versus Dolutegravir 50 Mg Twice Daily in HIV/TB Co-infected Patients Receiving Rifampin-based Antituberculosis Therapy
Enrollment Status: Recruiting
Publish Date: October 02, 2024
Intervention Type: Drug
Study Drug: Dolutegravir
Study Phase: Phase 2
A Phase 2/3, Multicenter, Open-label, Multicohort Study Evaluating Pharmacokinetics (PK), Safety, and Efficacy of Cobicistat-boosted Atazanavir (ATV/co) or Cobicistat-boosted Darunavir (DRV/co) and Emtricitabine/Tenofovir Alafenamide (F/TAF) in HIV-1 Infected, Virologically Suppressed Pediatric Participants
A Phase 2/3, Multicenter, Open-label, Multicohort Study Evaluating Pharmacokinetics (PK), Safety, and Efficacy of Cobicistat-boosted Atazanavir (ATV/co) or Cobicistat-boosted Darunavir (DRV/co) and Emtricitabine/Tenofovir Alafenamide (F/TAF) in HIV-1 Infected, Virologically Suppressed Pediatric Participants
Enrollment Status: Active_not_recruiting
Publish Date: June 26, 2025
Intervention Type: Drug
Study Drugs: Atazanavir, Darunavir, Cobicistat, Background regimen
Study Phase: Phase 2/Phase 3
Maintenance of Switching From Protease Inhibitor/Ritonavir to Generic Single Tablet Regimen of Tenofovir Alafenamide/Emtricitibine/Dolutegravir in Virologically Suppressed HIV-infected Adults
Maintenance of Switching From Protease Inhibitor/Ritonavir to Generic Single Tablet Regimen of Tenofovir Alafenamide/Emtricitibine/Dolutegravir in Virologically Suppressed HIV-infected Adults
Enrollment Status: Completed
Publish Date: February 28, 2024
Intervention Type: Drug
Study Drug: Generic Single Tablet Tenofovir Alafenamide/Emtricitibine/Dolutegravir
Study Phase: Phase 3
A Phase 1/2, Dose-finding Study to Evaluate Safety, Tolerability, and Immunogenicity of the ChulaCov19 Vaccine in Healthy Adults
A Phase 1/2, Dose-finding Study to Evaluate Safety, Tolerability, and Immunogenicity of the ChulaCov19 Vaccine in Healthy Adults
Enrollment Status: Completed
Publish Date: February 09, 2023
Intervention Type: Biological, Other
Study Phase: Phase 1/Phase 2
Innovation of Self-Assessment Tuberculin Skin Test for Latent TB Screening in HIV Patients
Innovation of Self-Assessment Tuberculin Skin Test for Latent TB Screening in HIV Patients
Enrollment Status: Completed
Publish Date: July 16, 2020
Intervention Type: Other
View 4 Less Clinical Trials

53 Total Publications

Dengue among immunocompromised patients: a systematic review and meta-analysis.
Dengue among immunocompromised patients: a systematic review and meta-analysis.
Journal: Journal of travel medicine
Published: June 15, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Gatechompol's expertise for a condition
ConditionClose
      View All 15 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile